Northern Trust Corp increased its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 5.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,690,402 shares of the technology company's stock after purchasing an additional 81,653 shares during the quarter. Northern Trust Corp owned approximately 0.18% of Koninklijke Philips worth $42,936,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in PHG. GAMMA Investing LLC lifted its stake in Koninklijke Philips by 3,094.8% in the first quarter. GAMMA Investing LLC now owns 350,241 shares of the technology company's stock valued at $8,896,000 after buying an additional 339,278 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Koninklijke Philips by 2.5% in the first quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company's stock valued at $111,662,000 after buying an additional 106,044 shares during the last quarter. Timber Creek Capital Management LLC lifted its stake in Koninklijke Philips by 512.5% in the first quarter. Timber Creek Capital Management LLC now owns 105,185 shares of the technology company's stock valued at $2,672,000 after buying an additional 88,012 shares during the last quarter. Quantinno Capital Management LP lifted its stake in Koninklijke Philips by 71.1% in the fourth quarter. Quantinno Capital Management LP now owns 180,149 shares of the technology company's stock valued at $4,561,000 after buying an additional 74,835 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in Koninklijke Philips by 58.4% in the fourth quarter. First Trust Advisors LP now owns 184,573 shares of the technology company's stock valued at $4,673,000 after buying an additional 68,071 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Koninklijke Philips has a consensus rating of "Buy".
View Our Latest Analysis on PHG
Koninklijke Philips Stock Performance
Shares of Koninklijke Philips stock traded up $0.10 during trading hours on Wednesday, hitting $27.16. 638,059 shares of the company were exchanged, compared to its average volume of 732,663. The business has a 50-day moving average of $25.98 and a 200-day moving average of $25.01. Koninklijke Philips N.V. has a 1 year low of $21.48 and a 1 year high of $32.91. The stock has a market capitalization of $26.15 billion, a price-to-earnings ratio of 142.92, a P/E/G ratio of 0.75 and a beta of 0.81. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69.
Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The firm had revenue of $5.05 billion for the quarter, compared to analyst estimates of $4.35 billion. As a group, analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
Koninklijke Philips Company Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.